Search research articles
Contact Us
Filters
Showing results (81-90 of 207) with videos related to
Page
of 21
Sort By:
Oncogene
|
April 30, 2013
SPROUTY2 is a β-catenin and FOXO3a target gene indicative of poor prognosis in colon cancer
P Ordóñez-Morán, A Irmisch, A Barbáchano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2014
Cyclin E amplification/overexpression is associated with poor prognosis in gastric cancer
M Alsina, S Landolfi, C Aura, et al.
Journal of Applied Toxicology : JAT
|
March 13, 2012
Hair testing for cocaine and metabolites by GC/MS: criteria to quantitatively assess cocaine use
O López-Guarnido, I Álvarez, F Gil, et al.
Research in Veterinary Science
|
August 6, 2013
Electrolyzed water as novel technology to improve hygiene of drinking water for dairy ewes
R Bodas, D J Bartolomé, M J Tabernero De Paz, et al.
Journal of Neonatal-Perinatal Medicine
|
May 13, 2014
Prenatal alcohol exposure and its repercussion on newborns
A Baña, M J Tabernero, A Pérez-Muñuzuri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2017
Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies
N Boeckx, R Koukakis, K Op de Beeck, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Surrogate to predict overall survival in patients with <i>BRAF</i> V600E-mutant colorectal cancer treated with BRAF inhibitor combinations
J Ros, V Navarro, G Villacampa, et al.
Oncology
|
August 28, 2004
Serial topoisomerase II expression in primary breast cancer and response to neoadjuvant anthracycline-based chemotherapy
M Martin-Richard, M Muñoz, J Albanell, et al.
ESMO Open
|
December 1, 2022
Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer
A H Awada, V Boni, V Moreno, et al.
ESMO Open
|
August 27, 2022
MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAF<sup>wt</sup> metastatic colorectal cancer
J Tabernero, A Grothey, D Arnold, et al.
Page
of 21
Search research articles
Search
Showing results (81-90 of 207) with videos related to
Sort By:
Page
of 21
Oncogene
|
April 30, 2013
SPROUTY2 is a β-catenin and FOXO3a target gene indicative of poor prognosis in colon cancer
P Ordóñez-Morán, A Irmisch, A Barbáchano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2014
Cyclin E amplification/overexpression is associated with poor prognosis in gastric cancer
M Alsina, S Landolfi, C Aura, et al.
Journal of Applied Toxicology : JAT
|
March 13, 2012
Hair testing for cocaine and metabolites by GC/MS: criteria to quantitatively assess cocaine use
O López-Guarnido, I Álvarez, F Gil, et al.
Research in Veterinary Science
|
August 6, 2013
Electrolyzed water as novel technology to improve hygiene of drinking water for dairy ewes
R Bodas, D J Bartolomé, M J Tabernero De Paz, et al.
Journal of Neonatal-Perinatal Medicine
|
May 13, 2014
Prenatal alcohol exposure and its repercussion on newborns
A Baña, M J Tabernero, A Pérez-Muñuzuri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2017
Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies
N Boeckx, R Koukakis, K Op de Beeck, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Surrogate to predict overall survival in patients with <i>BRAF</i> V600E-mutant colorectal cancer treated with BRAF inhibitor combinations
J Ros, V Navarro, G Villacampa, et al.
Oncology
|
August 28, 2004
Serial topoisomerase II expression in primary breast cancer and response to neoadjuvant anthracycline-based chemotherapy
M Martin-Richard, M Muñoz, J Albanell, et al.
ESMO Open
|
December 1, 2022
Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer
A H Awada, V Boni, V Moreno, et al.
ESMO Open
|
August 27, 2022
MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAF<sup>wt</sup> metastatic colorectal cancer
J Tabernero, A Grothey, D Arnold, et al.
Page
of 21